1. Adlercreutz, H.: Does fiber-rich food containing animal lignan precursors protect against
both colon and breast cancer? An extension of the “fiber hypothesis”. Gastroenterology,
1984; 86: 761-764.
2. Bingham, S.A., Atkinson, C., Liggins, J.: Phyto-oesterogens: Where are we now? Brit. J.
Nutr. 1998; 79: 393-406.
3. Brown, N.M., Setchell K.D.R.:Animal models impacted by phytoestrogens in commercial
chow: implications for pathways influenced by hormones. Lab. Invest.2001; 8: 735–747.
4. Brown, R.G., Hoag, G.N., Smart, M.E. et al:Alaskan malamute chondrodysplasia:
Decreased gut zinc absorption. Growth 1978; 42: 1.
5. Cardoso, J.R., Bao, S.N.: Effects of chronic exposure to soy meal containing diet or soy
derived isoflavones supplement on semen production and reproductive system of male
rabbits. Anim. Reprod. Sci. 2007; 97(3-4): 237-245.
6. Casanova, M., You, L., Gaido,K.W., Archibeque-Engle, S., Janszen, D.B., Heck, H.A.:
Developmental effects of dietary phytoestrogensin Sprague–Dawley rats and interactions of
genistein and daidzein with rat estrogen receptors alpha and beta in vitro. Toxicol. Sci.1999;
51 (2): 236–244
7. Cassidy, A., Hanley, B., Raventos, R.: Isoflavones, lignans and stilbens-origins,
metabolism and potential importance to human health. J. Sci. Food Agr. 2000; 80: 1044-1062.
8. Cerundolo, R., Court, M.H., Hao, Q., Michel, K.E.: Identification and concentration of
soy phytoestrogens in commercial dog foods. Am. J. Vet. Res.2004; 65(5): 592–596.
9. Clarkson, TB.: Soy, soy phytoestrogens and cardiovascular disease. J. Nutr. 2002; 132: 566-596.
10. Court, M.H., Freeman, L.M.: Identification and concentration of soy isoflavones in
commercial cat foods. Am. J. Vet. Res.2002; 63 (2): 181–185.
11. Court, M.H.:Surprised with feline hyperthyroidism study recommendation. J. Am. Vet.
Med. Assoc. 2004; 224 (10): 1582-3.
12. Coward, L., Barnes, N.C., Setchell, K.D.R., Barnes, S.: Genistein, daidzein, and their β-glycoside conjugates: antitumor isoflavones in soybean foods from American and Asian
diets. J. Agr. Food. Chem., 1993; 41: 1961–1967.
13. Davis, S., Dalais, F., Simpson, E., Murkies, A.:Phytoestrogens in health and disease.
Recent Progress In Hormone Research. 1999; 54: 185-211.
14. Demlow, B.M.¸ Duncan, A.M., Wangen, K.E., et al:Soy isoflavones improve plazma
lipits in normocholesterolemic, premenopausal women. Am. J. Clin. Nutr. 2000; 71: 1462-1469.
15. Doğan, K., Akyıldız, R.: "Soya: Üretimi, kalite kontrolü ve değerlendirilmesi. Yem
sanayicileri birliği yayınları, Ankara, 1985.
16. Fitzpatrick, L.A.: Selective estrogen receptor modulators and phytoesterogens: New
therapies for the postmenopausal women. Mayo. Clin. Proc. 1999; 74: 601-607.
17. Grayer, RJ., Harborne, J.B.: A survey of antifungal compounds from higher plants 1982-1993. Phytochemistry, 1994; 37: 19-42.
18. Jenkins, D.J.A., Kendall, C.W.C., Costa, M.A.D., Jackson, C-J.C., Vidgen, E., Singer,
W.: Soy consumption and phytoestrogens: Effect on serum prostate specific antigen when
blood lipids and oxidized low-density lipoprotein are reduced in hyperlipidemic men,
J.Urology, 2003; 169: 507–511.
19. Jha, H.C., Recklinghausen, G.V., Zilliken, F.:Inhibition of in vitro microsomal lipid
peroxidation by isoflavones. Biochem. Pharmacol., 1985; 34: 1367–1369.
20. Knight D.C., Eden J.A.:A review of the clinical effects of phytoestrogens. Obstet.
Gynecol. 1996; 87: 897-904.
21. Li, W., Seifert, M., Xu, Y., Hock, B.: Comparative study of estrogenic potencies of
estradiol, tamoxifen bisphenol-A and resveratrol with two in vitro bioassays. Environ. Int.
2004; 30: 329-335.
Handan AYDIN 58
22. McClain, M.R., Wolz, E., Davidovich, A., Pfannkuch, F., Bausch, J.:Subchronic and
chronic safety studies with genistein indogs. Food Chem. Toxicol. 2005; 43: 1461-1482.
23. Mesiano, S., Katz, S.L., Lee, J.Y., Jaffe, R.B.:Phytoestrogens alter adrenocortical
function: genistein and daidzein suppress glucocorticoid and stimulate androgen production
by cultured adrenal cortical cells. J. Clin. Endocrinol. Metab. 1999; 84 (7): 2443-2448.
24. Messina, M., Barnes, S.:The role of soy products in reducing risk of cancer. J. Natl. Cancer
Inst., 1991; 83: 541-546.
25. Messina, M., Persky, V., Setchell, K.D.R., Barnes, S.:Soy intake and cancer risk: a
review of the in vitro and in vivo data. Nutr. Cancer, 1994; 21: 113–131.
26. Nestel, P.J., Yamashita, T., Sasahara, T., et al:Soy isoflavones improvesystemic arterial
compliance but not plazma lipits in menopausaland perimenopausal women. Arterioscler.
Thromb. Vasc. Biol. 1997; 17: 3392-3398.
27. Packer, L., Hiramatsu, M., Toshikawa T.:Antioxidant Food Supplements in Human
Health, San Diego: Academic Press. 1999.
28. Plechner, A.J., Shannon M.:Canine immune complex diseases. Mod. Vet. Pract. 1976:917.
29. Pratt, D.E., Birac, P.M.:Source of antioxidant activity of soybeans and soy products, J.
Food Sci., 1979; 44: 1720–1722.
30. Puska, PP., Korpelainen, V., Hoie, LH.:Soy In Hypercholesterolaemia: A double- blind
plasebo-controlled trial. Eur.J. Clin. Nutr. 2002; 56: 352-357.
31. Reid, S.W.G., Peterson, M.M.:Methods of estimating caninelongevity. Vet. Rec., 2000;
147: 630-631
32. Robertson, B.T., Burns, M.J.:Zinc metabolism and the zinc-deficiency syndrome in the
dog. Am. J. Vet. Res. 1963: 997
33. Ruiz Larrea, M.B., Mohan, A.R., Paganga, G., Miller, N.J., Bolwell, G.P., Rice Evans,
C.A.: Antioxidant activity of phytoestrogen isoflavones, Free Radical Res., 1997; 26: 63–70.
34. Setchell, K.D.R., Gosselin, S.J., Welsh, M.B., Johnston, J.O., Balistreri, W.F., Kramer,
L.W., Dresser, B.L., Tarr, M.J.: Dietary estrogens-a problable cause of infertility and liver
disease in captive Cheetahs. Gastroenterology, 1987; 93: 225–233.
35. Sibbald, I.R.:The effect of heat on clearance time. True metabolizable energy and true
available amino acids on raw soybean flakes. Poultry Sci. 1980; 59: 2358-2360.
36. Song, T.T., Hendrich, S., Murphy, P.A.:Estrogenic Activity Of Glycitein, A Soy
Isoflavone. J.Agric. Food Chem. 1999; 47: 1607-1610.
37. Sweeney, T.:Is exposure to endocrine disrupting compounds during fetal/post-natal
development affecting the reproductive potential of farm animals? Domest. Anim.
Endocrinol. 2002 Jul; 23(1-2): 203-209.
38. Thigpen, J.E., Setchell, K.D., Ahlmark, K.B., Locklear, J., Spahr, T.:Phytoestrogen
content of purified open- and closed-formula laboratory animal diets. Lab. Anim. Sci. 1999;
49 (5): 530–536.
39. Umland, E.M., Pharm, D., Cauffield, J.S.:Phytoestrogens as therapeutic alternatives to
traditional hormone replacement in postmenopausal women. Pharmacotherapy, 2000; 20 (8):
981-990.
40. Verdrengh, M., Collins, L.V., Bergin, P., Tarkowski, A.:Phytoestrogen genistein as an
anti-staphylococcal agent. Microb.Infect. 2004; 6: 86-92.
41. Wei, H., Bowen, R., Cai, Q., Barnes, S., Wang, Y.:Antioxidant and antipromotional
effects of the soybean isoflavone genistein. P. Soc. Exp. Biol&Med., 1995; 208: 124–130.
42. White, H.L., Freeman, L.M., Mahony, O., Graham, P.A., Hao, Q., Court, M.H: Effect
of dietary soy on thyroid hormone concentrations in healthy adult cats. Am. J. Vet. Res.
2004; 65 (5): 586-591.
43. Wiseman, H., Reilly, J.D., Adlercreutz, H.:Isoflavone phytoestrogens consumed in soy
decrease F2-isoprostane concentrations and increase resistance of low-density lipoprotein to
oxidation in humans. Am. J. Clin. Nutr. 2000; 72: 395-400.
Thank you for copying data from http://www.arastirmax.com
